Back
Windtree Therapeutics Stock Price Chart

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
22
WINT
Windtree Therapeutics
Last Price:
$2.03
Seasonality Move:
-6.48%
7 Day Trial
ALL ACCESS PASS
$
7

AI Is Changing Marketing Forever-Invest Before the Boom
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and WINT is experiencing slight buying pressure.
Windtree Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.03 | Buy |
20-day SMA: | 3.79 | Sell |
50-day SMA: | 7.89 | Sell |
200-day SMA: | 129.37 | Sell |
8-day EMA: | 2.29 | Sell |
20-day EMA: | 3.68 | Sell |
50-day EMA: | 11 | Sell |
200-day EMA: | 262.41 | Sell |
Windtree Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.86 | Sell |
Relative Strength Index (14 RSI): | 22.68 | Sell |
Chaikin Money Flow: | 2798 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.21 - 6.51) | Sell |
Bollinger Bands (100): | (5.29 - 31.01) | Sell |
Windtree Therapeutics Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Windtree Therapeutics Stock
Is Windtree Therapeutics Stock a Buy?
-
Windtree Therapeutics share price is 2.05 while WINT 8-day simple moving average is 2.03, which is a Buy signal.
-
The stock price of WINT is 2.05 while Windtree Therapeutics 20-day SMA is 3.79, which makes it a Sell.
-
Windtree Therapeutics 50-day simple moving average is 7.89 while WINT share price is 2.05, making it a Sell technically.
-
WINT stock price is 2.05 and Windtree Therapeutics 200-day simple moving average is 129.37, creating a Sell signal.
WINT Technical Analysis vs Fundamental Analysis
Sell
22
Windtree Therapeutics (WINT)
is a Sell
Is Windtree Therapeutics a Buy or a Sell?
-
Windtree Therapeutics stock is rated a SellThe current Windtree Therapeutics [WINT] share price is $2.05. The Score for WINT is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Windtree Therapeutics Stock Info
Market Cap:
1.5M
Price in USD:
2.05
Share Volume:
36.4K
Windtree Therapeutics 52-Week Range
52-Week High:
737.44
52-Week Low:
1.78
Sell
22
Windtree Therapeutics (WINT)
is a Sell
Windtree Therapeutics Share Price Forecast
-
What is the Windtree Therapeutics stock price today?The Windtree Therapeutics stock price is 2.05 USD today.
-
Will WINT stock go up or go down?Windtree Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Windtree Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Windtree Therapeutics is overvalued.
Is Windtree Therapeutics Stock a Buy?
-
Windtree Therapeutics share price is 2.05 while WINT 8-day exponential moving average is 2.29, which is a Sell signal.
-
The stock price of WINT is 2.05 while Windtree Therapeutics 20-day EMA is 3.68, which makes it a Sell.
-
Windtree Therapeutics 50-day exponential moving average is 11.00 while WINT share price is 2.05, making it a Sell technically.
-
WINT stock price is 2.05 and Windtree Therapeutics 200-day simple moving average is 262.41, creating a Sell signal.
Fundamental Analysis of Windtree Therapeutics
Is Windtree Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $141.75 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Windtree Therapeutics
Should I short Windtree Therapeutics stock?
-
WINT Moving Average Covergence Divergence (MACD) indicator is -1.86, suggesting Windtree Therapeutics is a Sell
-
Windtree Therapeutics Relative Strength Index (RSI) is 22.68, which suggest Windtree Therapeutics is oversold
-
The Bollinger Bands (25) for Windtree Therapeutics is (2.21 - 6.51), which suggest Windtree Therapeutics is a Sell
-
The Bollinger Bands (100) for Windtree Therapeutics is (5.29 - 31.01), which suggest Windtree Therapeutics is a Sell
* Windtree Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.